Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
NAKAthis companyNakamoto Inc.	$5.60	-1.35×	0.31×	87.61×	-200.13×	-440.3%	-508.8%	-10824.0%	-2867.6%	-10.2%	-27.2%	-14.9%	0.41×	-4.17×	-27.92×	1.04×	0.0%	1	-4.78	2	C+
AGLAgilon Health, Inc.	$114.23	-0.7×	2.25×	0.05×	-0.4×	-1013.5%	-3.2%	-7.1%	-6.8%	-319.8%	-196.7%	-41.7%	0.29×	0.37×	-63.41×	1.02×	0.0%	3	2.2	1	C-
DCTHDelcath Systems, Inc.	$18.96	126.25×	3.25×	4.24×	82.74×	-1005.2%	86.2%	0.8%	3.2%	2.4%	0.5%	5.8%	0.01×	-11.02×	0×	10.92×	0.0%	5	15.11	2	B-
DHDefinitive Healthcare Corp.	$1.14	-2.21×	1.09×	1.27×	-2.22×	-728.9%	75.9%	-8.5%	-57.5%	-49.4%	-3.3%	12.1%	0.61×	-0.06×	-1.82×	1.64×	1.0%	6	-3.14	2	B-
LRMRLarimar Therapeutics, Inc.	$2.48	-1.68×	3.56×	0×	-1.19×	-55.3%	0.0%	0.0%	0.0%	-212.2%	-210.0%	-40.8%	0.05×	0.49×	0×	2.19×	0.0%	1	-2.84	2	C+
LYELLyell Immunopharma, Inc.	$16.08	-1.92×	2.12×	14,614.52×	-1.97×	-96.7%	-31952.8%	-566038.9%	-762355.6%	-110.6%	-68.0%	-28.7%	0.21×	0.03×	0×	5.28×	0.0%	1	-7.49	2	C+
Peer median	—	-1.68×	2.25×	1.27×	-1.19×	-728.9%	0.0%	-7.1%	-6.8%	-110.6%	-68.0%	-28.7%	0.21×	0.03×	0×	2.19×	0.0%	3	-2.84	2	—